Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
13.53
-0.13 (-0.95%)
At close: May 22, 2026, 4:00 PM EDT
13.53
0.00 (0.00%)
After-hours: May 22, 2026, 5:58 PM EDT
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $2.95 billion as of May 22, 2026. Its market cap has increased by 483.03% in one year.
Market Cap
2.95B
Enterprise Value
2.34B
1-Year Change
483.03%
Ranking
Category
Stock Price
$13.53
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.03B to $2.95B, a decrease of -2.84%. That is a compound annual growth rate of -0.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 2.98B | 103.03% |
| Dec 31, 2025 | 1.47B | 112.63% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IDEAYA Biosciences | 2.60B |
| Arcutis Biotherapeutics | 2.57B |
| Enliven Therapeutics | 2.52B |
| Disc Medicine | 2.50B |
| Vera Therapeutics | 2.48B |
| Celldex Therapeutics | 2.42B |
| Nektar Therapeutics | 2.32B |
| Immunome | 2.28B |